About us

On the 11th of November 2020 a contract-based alliance of ENCePP research centres called the SIGMA Consortium was launched. The launch of the SIGMA Consortium heralded a new era of collaboration to better understand safety and effectiveness of medical interventions. Research institutions compete for resources to carry out research; SIGMA aims to address this challenge by integrating expertise and data from multiple European Research Centres.

This collaborative research initiative, designed to be the ‘go-to’ organization for state-of-the-art methodological pharmacoepidemiology/RWE research, was assembled to enable multi-country studies using common analyses to study responses to treatments in large populations.

SIGMA Executive Committee start up members Prof Ron Herings (Netherlands) and Dr Susana Perez-Gutthann (Spain) said “The benefits and risks of treatments are of concern to every citizen. Our objective is to clarify and quantify these treatment effects for the citizens of Europe.”